Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.
| Brand name | BUPROPION HYDROCHLORIDE |
| Generic name | BUPROPION HYDROCHLORIDE |
| Active ingredient(s) | BUPROPION HYDROCHLORIDE |
| Distributed by / for | Actavis Inc |
| NDC | 0591-3331-30 |
| Full product label | BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880 |
| Recalling firm | Actavis Inc |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 139,944 bottles |
| Recall initiated | 2013-11-15 |
| Report date | 2014-02-05 |
| Recall completed | 2015-06-16 |
| Recall number | D-1043-2014 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗